Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Altmann

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Targeting of activated fibroblasts for imaging and therapyThomas Lindner, Anastasia Loktev, Frederik Giesel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Identification of Ligands and Translation to Clinical ApplicationsUwe Haberkorn, Walter Mier, Klaus Kopka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2003
Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatomaAnnette Altmann, Maria Kissel, Sabine Zitzmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2003
Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3)Stephanie Sieger, Shiming Jiang, Frank Schönsiegel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2012
Antitumor effects of proteasome inhibition in anaplastic thyroid carcinomaAnnette Altmann, Annette Markert, Vasileios Askoxylakis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Effects of Pax8 and TTF-1 thyroid transcription factor gene transfer in hepatoma cells: imaging of functional protein-protein interaction and iodide uptakeAnnette Altmann, Ralf B Schulz, Gabriela Glensch, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 19, 2020
Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular deliveryMax Sauter, Matthias Strieker, Christian Kleist, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 4, 2010
Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275Annette Altmann, Michael Eisenhut, Ulrike Bauder-Wüst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Identification of a new prostate-specific cyclic peptide with the bacterial FliTrx systemSabine Zitzmann, Susanne Krämer, Walter Mier, et al.
Angewandte Chemie (International Ed. in English)|February 28, 2014
A disulfide-constrained miniprotein with striking tumor-binding specificity developed by ribosome displayFrederic Zoller, Annette Markert, Philippe Barthe, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Targeting of activated fibroblasts for imaging and therapyThomas Lindner, Anastasia Loktev, Frederik Giesel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Identification of Ligands and Translation to Clinical ApplicationsUwe Haberkorn, Walter Mier, Klaus Kopka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2003
Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatomaAnnette Altmann, Maria Kissel, Sabine Zitzmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2003
Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3)Stephanie Sieger, Shiming Jiang, Frank Schönsiegel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2012
Antitumor effects of proteasome inhibition in anaplastic thyroid carcinomaAnnette Altmann, Annette Markert, Vasileios Askoxylakis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Effects of Pax8 and TTF-1 thyroid transcription factor gene transfer in hepatoma cells: imaging of functional protein-protein interaction and iodide uptakeAnnette Altmann, Ralf B Schulz, Gabriela Glensch, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 19, 2020
Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular deliveryMax Sauter, Matthias Strieker, Christian Kleist, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 4, 2010
Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275Annette Altmann, Michael Eisenhut, Ulrike Bauder-Wüst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Identification of a new prostate-specific cyclic peptide with the bacterial FliTrx systemSabine Zitzmann, Susanne Krämer, Walter Mier, et al.
Angewandte Chemie (International Ed. in English)|February 28, 2014
A disulfide-constrained miniprotein with striking tumor-binding specificity developed by ribosome displayFrederic Zoller, Annette Markert, Philippe Barthe, et al.
Pageof 6